Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Just Happy to be on Board

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Aug 29, 2018 11:35am

83 Views

Post# 28535843

RE:Just Happy to be on Board

Still need lots of volume here and I feel
that we don’t see any until or before news is ready to come through.
we also are holding very tight in this range so I believe we are headed up from here simply because of the accumulation pattern

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading